ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 83 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,874,000 | -39.9% | 707,746 | 0.0% | 0.78% | +27.2% |
| Q3 2018 | $9,767,000 | +182.9% | 707,746 | +62.9% | 0.62% | +177.0% |
| Q2 2018 | $3,453,000 | +42.1% | 434,344 | +34.0% | 0.22% | +40.5% |
| Q1 2018 | $2,430,000 | +117.4% | 324,019 | +97.1% | 0.16% | +4.6% |
| Q4 2017 | $1,118,000 | – | 164,384 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,400,239 | $6,224,000 | 4.02% |
| Tri Locum Partners LP | 1,447,445 | $6,434,000 | 2.51% |
| Knoll Capital Management, LLC | 759,405 | $3,376,000 | 2.12% |
| Perceptive Advisors | 9,903,879 | $44,023,000 | 0.88% |
| JOHNSON & JOHNSON | 394,834 | $1,755,000 | 0.33% |
| APOGEM CAPITAL LLC | 104,042 | $462,000 | 0.32% |
| Ikarian Capital, LLC | 375,000 | $1,667,000 | 0.22% |
| 683 Capital Management, LLC | 500,000 | $2,223,000 | 0.12% |
| Verition Fund Management LLC | 2,105,907 | $9,361,000 | 0.11% |
| Palo Alto Investors LP | 160,800 | $715,000 | 0.06% |